96 results on '"Barabassy, A."'
Search Results
2. The Transdiagnostic Global Impression - Psychopathology scale (TGI-P): Initial development of a novel transdiagnostic tool for assessing, tracking, and visualising psychiatric symptom severity in everyday practice
3. Single trajectory treatment response for predominant negative symptoms: Post-hoc analysis of a clinical trial with cariprazine and risperidone
4. Cariprazine and akathisia, restlessness, and extrapyramidal symptoms in patients with bipolar depression
5. Efficacy of cariprazine on negative symptoms in patients with acute schizophrenia: A post hoc analysis of pooled data
6. Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial
7. Negative Symptoms of Schizophrenia: Constructs, Burden, and Management
8. Time course of adverse events – descriptive data analysis of a schizophrenia relapse prevention trial of cariprazine
9. Cariprazine 3 mg/d in bipolar depression – post hoc analysis of pooled study data
10. Cognitive estimation in aged patients with major depressive disorder
11. P.0904 Results of a phase 1 trial investigating the effect of cariprazine on the pharmacokinetics of a combined oral contraceptive
12. P.0676 Efficacy of cariprazine in bipolar I disorder in light of its receptor profile
13. The application of near infrared spectroscopy (NIR) technique for
14. P.0676 Efficacy of cariprazine in bipolar I disorder in light of its receptor profile
15. P.0904 Results of a phase 1 trial investigating the effect of cariprazine on the pharmacokinetics of a combined oral contraceptive
16. Cognitive estimation in mild Alzheimer’s disease
17. P.575 Long-term functional improving effects of cariprazine: post-hoc analyses of acute and predominant negative symptom schizophrenia patient data
18. P.572 Safety with or without treatment: a post-hoc analysis comparing stable patients discontinuing cariprazine treatment versus patients taking cariprazine long-term
19. P.576 The effect of cariprazine on agitation and hostility in patients with schizophrenia: post-hoc analysis
20. P.573 Efficacy of cariprazine in the early stage of schizophrenia: a pooled, post-hoc analysis of 3 phase II/III double-blind placebo-controlled trials
21. [Cariprazine, a new type - dopamine D₃ receptor preferring - partial agonist atypical antipsychotic for the treatment of schizophrenia and the primary negative symptoms]
22. Cariprazine, a selective dopamine D3 receptor partial agonist with unique features to treat schizophrenia negative and cognitive symptoms
23. Improvement of Schizophrenia Social Amotivation and Expressive Deficits Over Time After Cariprazine and Risperidone Treatment: Post Hoc Analysis of a Phase-3 Trial
24. Hormonal Effects of Cariprazine: Post Hoc Analysis of Pooled Data From Schizophrenia Studies for Sexual Dysfunction and Prolactin Changes
25. P.456 Akathisia during cariprazine treatment: Post-hoc analyses of pooled schizophrenia studies
26. Negative Symptoms of Schizophrenia : Constructs, Burden, and Management
27. Cariprazine, a selective dopamine D3 receptor partial agonist with unique features to treat schizophrenia negative and cognitive symptoms
28. Efficacy of cariprazine in the treatment of negative symptoms of schizophrenia: Post hoc analyses versus aripiprazole
29. P.456 Akathisia during cariprazine treatment: Post-hoc analyses of pooled schizophrenia studies
30. P.388 Clinical improvement of patients with predominant negative symptoms of schizophrenia: Post-hoc analysis of cariprazine versus risperidone
31. P.387 Correlation analysis of symptomatic and functional improvements of patients with predominant negative symptom of schizophrenia
32. S.08.05 Cariprazine, the new broad spectrum antipsychotic: Clinical data of schizophrenia, bipolar mania, bipolar depression and major depression studies
33. Safety profile of cariprazine: Post hoc analysis of safety parameters of pooled cariprazine schizophrenia studies
34. Cariprazine, a selective dopamine D3 receptor partial agonist with unique features to treat schizophrenia negative and cognitive symptoms
35. Efficacy of cariprazine in the treatment of negative symptoms of schizophrenia: Post hoc analyses versus aripiprazole
36. Cariprazine vs risperidone efficacy on predominant negative symptoms of schizophrenia: Post hoc analysis of negative symptoms subdomains
37. Safety profile of cariprazine in patients with predominant negative symptoms of schizophrenia
38. P.388 Clinical improvement of patients with predominant negative symptoms of schizophrenia: Post-hoc analysis of cariprazine versus risperidone
39. Safety profile of cariprazine: Post hoc analysis of safety parameters of pooled cariprazine schizophrenia studies
40. S.08.05 Cariprazine, the new broad spectrum antipsychotic: Clinical data of schizophrenia, bipolar mania, bipolar depression and major depression studies
41. Cariprazine, a selective dopamine D3 receptor partial agonist with unique features to treat schizophrenia negative and cognitive symptoms
42. Improvement of Schizophrenia Social Amotivation and Expressive Deficits Over Time After Cariprazine and Risperidone Treatment: Post Hoc Analysis of a Phase-3 Trial
43. Hormonal Effects of Cariprazine: Post Hoc Analysis of Pooled Data From Schizophrenia Studies for Sexual Dysfunction and Prolactin Changes
44. P.572 Safety with or without treatment: a post-hoc analysis comparing stable patients discontinuing cariprazine treatment versus patients taking cariprazine long-term
45. P.573 Efficacy of cariprazine in the early stage of schizophrenia: a pooled, post-hoc analysis of 3 phase II/III double-blind placebo-controlled trials
46. P.576 The effect of cariprazine on agitation and hostility in patients with schizophrenia: post-hoc analysis
47. P.575 Long-term functional improving effects of cariprazine: post-hoc analyses of acute and predominant negative symptom schizophrenia patient data
48. Cariprazine vs risperidone efficacy on predominant negative symptoms of schizophrenia: post hoc analysis of negative symptoms subdomains
49. Safety profile of cariprazine in patients with predominant negative symptoms of schizophrenia
50. Cariprazine vs risperidone efficacy on predominant negative symptoms of schizophrenia: post hoc analysis of negative symptoms subdomains
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.